AC
CVS icon

AlphaCore Capital’s CVS Health CVS Stock Holding History

AlphaCore Capital’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.4M Buy
32,868
+6,526
+25% +$583K 0.06% 233
2026
Q1 		$1.89M Sell
26,342
-2,512
-9% -$194K 0.04% 262
2025
Q4 		$2.29M Buy
28,854
+10,277
+55% +$810K 0.05% 246
2025
Q3 		$1.4M Buy
18,577
+15,434
+491% +$1.06M 0.05% 237
2025
Q2 		$217K Buy
3,143
+274
+10% +$18K 0.01% 561
2025
Q1 		$194K Buy
+2,869
New +$172K 0.02% 448
2024
Q4 		– Sell
-4,039
Closed -$254K – 265
2024
Q3 		$254K Sell
4,039
-1,158
-22% -$67.6K 0.06% 177
2024
Q2 		$307K Sell
5,197
-1,068
-17% -$66.8K 0.07% 150
2024
Q1 		$500K Buy
+6,265
New +$479K 0.13% 96
2020
Q3 		– Sell
-1,629
Closed -$106K – 59
2020
Q2 		$106K Hold
1,629
– – 0.11% 37
2020
Q1 		$97K Buy
+1,629
New +$109K 0.08% 74

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

AlphaCore Capital's CVS Position: Q2 2026 in Review

AlphaCore Capital increased its CVS Health (CVS) stake by 25% in Q2 2026, buying an estimated $583K and bringing the position to 32,868 shares worth $3.4M. The position accounts for 0.06% of the portfolio, ranked #233.

AlphaCore Capital first reported a position in CVS in Q1 2020 and has held it in 11 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • AlphaCore Capital held 32,868 shares of CVS Health worth $3.4M as of Q2 2026.
  • AlphaCore Capital bought 6,526 CVS Health shares in Q2 2026, an estimated $583K.
  • CVS Health made up 0.06% of AlphaCore Capital's portfolio in Q2 2026, its #233 holding.
  • AlphaCore Capital first reported a position in CVS Health in Q1 2020 and has held it in 11 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.